Oncology Devices
The U.S. oncology device market is advancing with increasing cancer incidence, precision medicine, and innovative diagnostic and treatment technologies. Our research provides actionable insights into market size, technology adoption, competitive dynamics, and future growth across oncology devices.
The U.S. Radiation Oncology Devices Market is projected to grow from USD 3.62 billion in 2025 to USD 8.44 billion by 2035 at an 8.83% CAGR, driven by adaptive radiotherapy, precision imaging, stereotactic treatment, proton therapy, and oncology equipment modernization.
Read Report Details
The U.S. Cancer Care Equipment Market is projected to grow from USD 39.50 billion in 2025 to USD 87.51 billion by 2035 at an 8.28% CAGR, supported by radiation therapy modernization, advanced oncology imaging, robotic surgery, interventional oncology, and AI-enabled treatment systems.
Read Report Details
The U.S. Hospital Oncology Devices Market is projected to rise from USD 24.80 billion in 2025 to USD 65.50 billion by 2035, expanding at a 10.20% CAGR as hospitals invest in radiation oncology, robotic surgery, interventional oncology, digital pathology, and AI-enabled cancer-care technologies.
Read Report Details
The U.S. Ambulatory Oncology Devices Market is projected to grow from USD 18.70 billion in 2025 to USD 45.09 billion by 2035 at a 9.20% CAGR, driven by outpatient cancer treatment, smart infusion systems, vascular access devices, minimally invasive oncology procedures, and connected monitoring.
Read Report Details
The U.S. Personalized Cancer Care Devices Market is projected to rise from USD 17.25 billion in 2025 to USD 50.55 billion by 2035, driven by genomic profiling, companion diagnostics, liquid biopsy, MRD testing, digital pathology and AI-enabled precision oncology.
Read Report Details
The U.S. Image-Guided Oncology Devices Market is projected to grow from USD 7.26 billion in 2025 to USD 19.39 billion by 2035 at a 10.32% CAGR, supported by adaptive radiotherapy, image-guided ablation, robotic navigation, MRI-guided treatment, and precision oncology workflows.
Read Report Details
The U.S. Minimally Invasive Oncology Devices Market is projected to grow from USD 11.80 billion in 2025 to USD 38.15 billion by 2035, supported by robotic oncology surgery, image-guided tumor ablation, focal therapies, interventional oncology, and increasing demand for organ-preserving cancer treatment.
Read Report Details
The U.S. Precision Oncology Devices Market is projected to grow from USD 10.85 billion in 2025 to USD 35.71 billion by 2035, driven by genomic profiling, liquid biopsy, companion diagnostics, digital pathology, AI-enabled oncology diagnostics, and molecular imaging.
Read Report Details
The U.S. Cancer Diagnostic Devices Market is projected to grow from USD 31.86 billion in 2025 to USD 77.38 billion by 2035 at a 9.28% CAGR, driven by advanced imaging, precision biopsy, digital pathology, AI-assisted diagnostics, and expanding cancer screening.
Read Report Details
The U.S. Cancer Treatment Devices Market is projected to grow from USD 13.20 billion in 2025 to USD 36.81 billion by 2035 at a 10.80% CAGR, driven by precision radiation therapy, tumor ablation, robotic oncology, interventional treatments, histotripsy, and advanced treatment platforms.
Read Report Details